Ascendis Pharma A/S announced that it has appointed Mark A. Bach, M.D., Ph.D., as Senior Vice President of Clinical Development and Medical Affairs for Endocrinology Rare Diseases. Dr. Bach is a pediatric endocrinologist with 30 years of experience in clinical research and development. He has extensive global experience building and leading clinical teams that have successfully launched innovative pharmaceutical products into global markets. Until recently, he served as the Head of Asia Pacific Medical Sciences for Janssen Pharmaceutical Co. Prior to Janssen, he was Vice President of Clinical Research Operations Worldwide for Merck & Co. Inc. Dr. Bach is a recognized expert on endocrinology research, has lectured widely in national and international forums and served on numerous professional society advisory boards to advance the field of endocrinology and clinical research. He has published extensively including dozens of original research articles, review articles and scientific abstracts. Dr. Bach received his medical degree from Baylor College of Medicine in Houston, Texas; his doctorate degree from the University of Chicago, Illinois; and his bachelor’s degree from the Carleton College in Northfield, Minnesota.